SCH-79687
SCH-79687
SCH-79687 (pronunciation: /ˈɛsˈsiˈeɪtʃˈsevənˈnaɪnˈsɪksˈeɪtʃˈsevən/) is a pharmaceutical compound with potential therapeutic applications. The compound is still in the experimental stages and has not yet been approved for use in humans.
Etymology
The name "SCH-79687" is a systematic name, following the naming conventions of pharmaceutical compounds. "SCH" is an abbreviation for Schering-Plough, the pharmaceutical company that first synthesized the compound. The numbers "79687" are a unique identifier for this specific compound within the company's catalog.
Related Terms
- Pharmaceutical compound: A substance that is in the process of being studied to determine its potential therapeutic uses.
- Therapeutic: Pertaining to the treatment, remediation, or cure of a health condition.
- Schering-Plough: A multinational pharmaceutical company, now part of Merck & Co..
See Also
External links
- Medical encyclopedia article on SCH-79687
- Wikipedia's article - SCH-79687
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski